$0.26
-0.02 (-7.01%)
Open$0.27
Previous Close$0.28
Day High$0.27
Day Low$0.25
52W High$5.50
52W Low$0.15
Volume—
Avg Volume12.93M
Market Cap9.33M
P/E Ratio—
EPS$-7.14
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.85M | 7.13M | 6.14M |
| Net Income | -1,263,411 | -1,351,255 | -906,681 |
| Profit Margin | -18.4% | -19.0% | -14.8% |
| EBITDA | -2,085,898 | -2,131,542 | -1,625,986 |
| Free Cash Flow | -871,023 | -1,277,993 | -924,733 |
| Rev Growth | +20.2% | +21.4% | +12.5% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |